The EU AI Act: Implications for Startups, Innovation, and Investment | LSI Europe '24

This panel took place at LSI Europe ‘24 Emerging Medtech Summit in Sintra, Portugal.The recent EU AI Act has significant penalties and implications for existing and prospecting tech companies and investors. This panel covers these new policies from the perspective of Medtech innovators.This panel featured:Sophie Ehrlich — EIT Health Anjany Sekuboyina — Bonescreen Andreu Climent — Corify CareAndreas Schriefl — eMurmur Jordina Arcal — MJN NeuroserveisJoin us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summitsFollow us on social:LinkedIn: https://www.linkedin.com/company/life-science-intelligence/Twitter: https://twitter.com/lsintelligenceInstagram: https://www.instagram.com/lifescienceintelligence/Facebook: https://www.facebook.com/LifeScienceIntelligence/Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw

There are no comments yet.

Please log in to write the first comment.